企業プロフィール
Calliditas Therapeutics AB 株価・ニュース・カタリスト
- ティッカー:
- CALT
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- Sweden
株価変動の要因
Current closing-price context is not available for CALT.
企業概要
事業概要
Calliditas Therapeutics was a rare-disease and kidney-disease company focused on IgA nephropathy and related conditions before becoming a historical ticker. Its business reflected the value of specialty renal therapeutics in orphan disease.
所在地とセクター分類
Calliditas was headquartered in Sweden and listed on NASDAQ. It sat in rare-disease biotechnology.
ビジネスモデルの特徴
The company depended on clinical success, label expansion, and commercial execution in a focused nephrology market. Investors watched regulatory progress and launch performance.
バイオ業界での位置付け
Calliditas belongs to the historical rare-disease kidney bucket. It was a premium specialty biotech story before its strategic transition and legacy status.
今後のカタリスト
- Calliditas is now largely a legacy / closeout story, with catalysts limited to any strategic or asset-resolution update. The market no longer treats it like a live growth name.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。